DK0491361T3 - Korte peptider med insulinvirkning - Google Patents

Korte peptider med insulinvirkning

Info

Publication number
DK0491361T3
DK0491361T3 DK91121624T DK91121624T DK0491361T3 DK 0491361 T3 DK0491361 T3 DK 0491361T3 DK 91121624 T DK91121624 T DK 91121624T DK 91121624 T DK91121624 T DK 91121624T DK 0491361 T3 DK0491361 T3 DK 0491361T3
Authority
DK
Denmark
Prior art keywords
amino acid
short peptides
covalent bond
insulin action
formula
Prior art date
Application number
DK91121624T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Dr Koenig
Stefan Dr Muellner
Guenter Dr Mueller
Original Assignee
Hoechst Ag
Aventis Res & Tech Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Aventis Res & Tech Gmbh & Co filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0491361T3 publication Critical patent/DK0491361T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91121624T 1990-12-19 1991-12-17 Korte peptider med insulinvirkning DK0491361T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19

Publications (1)

Publication Number Publication Date
DK0491361T3 true DK0491361T3 (da) 1999-10-11

Family

ID=6420676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91121624T DK0491361T3 (da) 1990-12-19 1991-12-17 Korte peptider med insulinvirkning

Country Status (24)

Country Link
US (1) US5461035A (xx)
EP (1) EP0491361B1 (xx)
JP (2) JP3378588B2 (xx)
KR (1) KR100237948B1 (xx)
AT (1) ATE177753T1 (xx)
AU (1) AU643349B2 (xx)
CA (1) CA2058020C (xx)
CZ (1) CZ284568B6 (xx)
DE (1) DE59109109D1 (xx)
DK (1) DK0491361T3 (xx)
ES (1) ES2130130T3 (xx)
FI (1) FI105816B (xx)
GR (1) GR3030510T3 (xx)
HR (1) HRP940839B1 (xx)
HU (1) HU222493B1 (xx)
IE (1) IE914408A1 (xx)
IL (1) IL100400A (xx)
NO (1) NO308951B1 (xx)
NZ (1) NZ241029A (xx)
PT (1) PT99850B (xx)
SK (2) SK282361B6 (xx)
TW (1) TW227004B (xx)
YU (1) YU189891A (xx)
ZA (1) ZA919938B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
DE60204847T2 (de) * 2001-01-15 2006-05-11 Société de Technologie Michelin Formgebungstrommel für die reifenherstellung
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (xx) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
GR3030510T3 (en) 1999-10-29
KR920012115A (ko) 1992-07-25
ZA919938B (en) 1992-09-30
EP0491361B1 (de) 1999-03-17
NO308951B1 (no) 2000-11-20
US5461035A (en) 1995-10-24
IL100400A (en) 1998-01-04
HU222493B1 (hu) 2003-07-28
AU643349B2 (en) 1993-11-11
DE59109109D1 (de) 1999-04-22
TW227004B (xx) 1994-07-21
FI915933A (fi) 1992-06-20
AU8982591A (en) 1992-06-25
HU914009D0 (en) 1992-03-30
NO914999D0 (no) 1991-12-18
PT99850B (pt) 1999-06-30
NZ241029A (en) 1993-01-27
HUT59697A (en) 1992-06-29
HRP940839B1 (en) 2000-02-29
SK282360B6 (sk) 2002-01-07
YU189891A (sh) 1995-10-03
KR100237948B1 (ko) 2000-01-15
IL100400A0 (en) 1992-09-06
IE914408A1 (en) 1992-07-01
CA2058020C (en) 2003-10-28
CA2058020A1 (en) 1992-06-20
JP2003176237A (ja) 2003-06-24
ATE177753T1 (de) 1999-04-15
EP0491361A3 (en) 1993-11-24
PT99850A (pt) 1992-11-30
FI105816B (fi) 2000-10-13
JPH04295496A (ja) 1992-10-20
SK282361B6 (sk) 2002-01-07
CZ284568B6 (cs) 1999-01-13
JP3378588B2 (ja) 2003-02-17
FI915933A0 (fi) 1991-12-17
NO914999L (no) 1992-06-22
ES2130130T3 (es) 1999-07-01
JP3802863B2 (ja) 2006-07-26
EP0491361A2 (de) 1992-06-24
HRP940839A2 (en) 1997-06-30
CS387991A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
AU1563588A (en) Pasteurizable, freeze-driable hemoglobin-based blood substitute
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
PT711305E (pt) Protegrinas
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
NO923252D0 (no) Fosfoinositolglykan-peptid med insulinlignende virkning
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
FI892185A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
DK0491361T3 (da) Korte peptider med insulinvirkning
DE60228136D1 (de) Cytokin-proteinfamilie
EP0326490A3 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
ATE83381T1 (de) Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
DE69203098D1 (de) Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen.
SE7706567L (sv) Biologiskt aktiva peptider